This is a firm fixed price purchase order awarded by the Veterans Integrated Service Network 21 (VISN 21), a civilian agency within the U.S. Department of Veterans Affairs (VA), to Cytopath Biopsy Lab Inc. (doing business as Cblpath) for $596,768.17. The contract is for the provision of the ThyroSeq V3 Classifier CPT, a molecular diagnostic test used for thyroid cancer screening and diagnosis.
Cytopath Biopsy Lab Inc. has a history of providing specialized thyroid cancer testing services to the VA and the Defense Health Agency, delivering ThyroSeq testing kits and reagents to support cancer screening programs at VA and military medical facilities. This award is not set aside and is part of a larger Indefinite Delivery/Indefinite Quantity (IDIQ) contract vehicle and Blanket Purchase Agreement (BPA) that Cytopath Biopsy Lab Inc. holds with various VA regional networks to procure ThyroSeq testing services over multiple years. The contract has an ultimate completion date of August 4, 2029.
Generated 8/20/24, 9:07 AM